首页> 中文期刊> 《中国肿瘤临床》 >组蛋白乙酰化修饰调控RAR-β2表达与宫颈病变的相关性

组蛋白乙酰化修饰调控RAR-β2表达与宫颈病变的相关性

         

摘要

目的:探讨组蛋白乙酰化修饰与RAR-β2表达及宫颈病变发生发展的关系。方法:收集正常宫颈、宫颈上皮内瘤变(cervical intraepithelial neoplasia,CIN)Ⅱ~Ⅲ和宫颈鳞状细胞癌(squamous cell carcinoma,SCC)组织,分别采用免疫组织化学和Western Blot方法检测AcH3、RAR-β2和Involucrin的表达;分析组蛋白乙酰化水平与RAR-β2表达及宫颈病变程度的关系。结果:随着宫颈病变的进展,AcH3、RAR-β2和Involucrin的表达逐渐降低,甚至缺失,组间差异有统计学意义(P<0.05);组蛋白乙酰化水平与RAR-β2表达呈正相关(r=0.797,P<0.05),AcH3和RAR-β2的表达均与宫颈病变程度呈负相关[r=-0.547(AcH3),r=-0.585(RAR-β2), P<0.05]。结论:组蛋白乙酰化修饰与RAR-β2表达调控有关,并可能参与宫颈癌的发生。%Objective:To investigate the relationship between cervical lesion development and histone acetylation that regulates RAR-β2 expression. Methods:Immunohistochemistry and Western blot analysis were performed to detect AcH3, RAR-β2, and involu-crin expression in normal cervical tissues as well as in tissues with cervical intraepithelial neoplasia (CIN)Ⅱ-Ⅲand squamous cell cer-vical carcinoma. The relationship among histone acetylation level, RAR-β2 expression, and cervical lesion severity were analyzed. Re-sults:AcH3, RAR-β2, and involucrin expression were reduced or absent with the progression of cervical lesions;significant differences were noted between the groups (P<0.05). Histone acetylation level and RAR-β2 expression were positively correlated (r=0.797, P<0.05). AcH3 and RAR-β2 expression, which were both associated with the cervical lesions, were negatively correlated [r=-0.547(AcH3), r=-0.585(RAR-β2), P<0.05]. Conclusion:Histone acetylation modification is associated with the regulation of RAR-β2 expression. This pro-cess is also likely to participate in the carcinogenesis of cervical carcinoma.

著录项

  • 来源
    《中国肿瘤临床》 |2014年第5期|300-304|共5页
  • 作者单位

    安徽医科大学附属省立医院妇产科;

    安徽省分子医学重点实验室 合肥市230001;

    安徽医科大学附属省立医院妇产科;

    安徽省分子医学重点实验室 合肥市230001;

    安徽医科大学附属省立医院妇产科;

    安徽省分子医学重点实验室 合肥市230001;

    安徽医科大学附属省立医院妇产科;

    安徽省分子医学重点实验室 合肥市230001;

    安徽医科大学附属省立医院妇产科;

    安徽省分子医学重点实验室 合肥市230001;

    安徽医科大学附属省立医院妇产科;

    安徽省分子医学重点实验室 合肥市230001;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类
  • 关键词

    组蛋白乙酰化修饰; RAR-β2; 宫颈上皮内瘤变; 宫颈鳞状细胞癌; 分化;

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号